Video

Komen NYC Educates Women About Breast Cancer Screening

Author(s):

Linda Tantawi, CEO of Susan G. Komen Greater New York City, discussed the organization’s events that serve as the “pink ribbon connecting the community” and some of their upcoming initiatives to help educate women about breast cancer screening and treatment.

Linda Tantawi, CEO of Susan G. Komen Greater New York City, discussed the organization’s events that serve as the “pink ribbon connecting the community” and some of their upcoming initiatives to help educate women about breast cancer screening and treatment.

Komen’s Third Annual Patient Navigation Initiative will be held June 25, which will have both lay and nurse navigators to discuss what is and isn’t working in patient navigation in the breast cancer space. The discussion will also include who is funding patient navigation, as it is currently not reimbursable through insurance.

In addition, the Sisters for the Cure event will be held on June 29. “It is our effort to really address the disparities in the African American community,” said Tantawi. “We know that African American women are 40% more likely to die from breast cancer than white women, and that is unacceptable.” This initiative will look into what can be done to ensure that African American women have the same quality and access to care as their white counterparts.

Lastly, the NY Metastatic Breast Cancer Conference will be held Oct. 5 through 6. At this event, “we bring the best researchers from all across the country right to New York (for) patients who wouldn’t have access to those researchers,” said Tantawi. “They don’t go to San Antonio, they can’t come here to ASCO, so let’s bring that information right to them.”

To learn more, visit komennyc.org.

Related Videos
Dr. Maxwell Lloyd, a Clinical Fellow in Medicine in the Department of Medicine at Beth Israel Deaconess Medical Center in Boston.
Dr. Michael Bogenschutz
Photo credit: Max Mumby/Indigo via Getty Images
Dr. Maxwell Lloyd, a Clinical Fellow in Medicine, in the Department of Medicine, at Beth Israel Deaconess Medical Center in Boston.
Dr. Stephanie Alice Baker
Dr. Aditya Bardia is a professor in the Department of Medicine, Division of Hematology/Oncology, director of Translational Research Integration, and a member Signal Transduction and Therapeutics, at University of California, Los Angeles (UCLA) Health Jonsson Comprehensive Cancer Center.
Dr. Laura Dawson, a professor and chair of the department of Radiation Oncology at the University of Toronto, and a practicing radiation oncologist in the Radiation Medicine Program at Princess Margaret Cancer Center, University Health Network in Toronto.
Dr. Sattva S. Neelapu, a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Michael Bogenschutz, director of the NYU Langone Center for Psychedelic Medicine in New York,